The company had announced the expected date of completion of sale and disposal of the said undertaking is 90 days from the date of signing the Definitive Agreements.
Regulatory clearance strengthens company’s global footprint and expands access to the Australian animal healthcare market
US formulations grew 11% to Rs. 564 crore as Alembic enters US branded pharmaceuticals market with launch of Pivya
With over 30 years of pharmaceutical industry experience, Ponnusamy will lead Alembic’s animal health business strategy, market expansion, and operational growth initiatives
In his new role, he is expected to further strengthen Zenex Animal Health’s market position and accelerate its next phase of growth.
VievePharm is renowned for its phytogenic formulations across livestock, equine, and pet care markets
The Poultry Healthcare Division delivered a strong performance, posting 32% revenue growth in Q3 FY26 and 17% growth over the nine-month period
The India Branded Business delivered a 5% YoY growth, reaching Rs. 599 crore in revenue for the quarter
The pet dog population alone is expected to increase from 21.4 million in 2019 to 51.5 million by 2028
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
